CTNNB1 and hemoglobin measurement: Several previous preclinical and clinical studies in HB have shown that the activation of Wnt/β-catenin signaling is driven by somatic mutations in exon 3 of the CTNNB1 (β-catenin) gene, which increases nuclear translocation of β-catenin.